…y, Portugal and Spain among people with CF (PwCF) who initiated elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) August 2019 – June 2023. We …
elexacaftor
This drug is selected. Its supporting articles are shown below.
Articles mentioning elexacaftor
12 articles · page 1 of 1…e and 7 had transitioned from prior modulator treatment (3 from Ivacaftor and 4 from Symkevi) table 1. All are still on ETI therapy and h…
…37% (p<0.001). ETI accounted for 160 cases (64.5%), followed by ivacaftor 57 (23.0%), lumacaftor/ivacaftor 23 (9.3%), and tezacaftor/ivac…
…lnutrition, chronic inflammation, and progressive lung decline. Elexacaftor/tezacaftor/ivacaftor (ETI) has transformed disease management, …
…ced expiratory volume in 1 s (FEV 1) ≥40% predicted), stable on Elexacaftor/Tezacaftor/Ivacaftor, were recruited, of whom 48 were randomly …
… reports of beneficial effects of CFTR modulators, particularly elexacaftor/tezacaftor/ivacaftor (ETI), on the rates of NTM acquisition and…
… ongoing real-world observational study, previously showed that elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) improves clinical outcomes a…
…ith CF has allowed the clinical team to measure the response to Elexacaftor/Tezacaftor/Ivacaftor (ETI) therapy using pre and post LCI in a …
…udomonas aeruginosa (Pa) after ≥6 months of the CFTR modulator, Elexacaftor/Tezacaftor/Ivacaftor (ETI).Methods Retrospective review of pwCF…
…duction Since widespread availability of highly effective CFTRm elexacaftor/tezacaftor/ivacaftor, pregancy rates have doubled among fwCF in…
…inflammation in people with cystic fibrosis (CF) established on elexacaftor/tezacaftor/ivacaftor (ETI) therapy. As CF is a multi-system dis…
…ts and children 4 months to 5 years of age who are eligible for elexacaftor/tezacaftor/ivacaftor (ETI) or ivacaftor (IVA) meet the inclusio…